venetoclax-based regimens for unfit patients with aml
Published 4 years ago • 114 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
6:45
venetoclax-based regimens as first-line therapy in aml
-
2:21
real-world data on venetoclax-based regimens for patients with aml or mds with excess blasts-2
-
4:03
venetoclax for aml
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
3:45
venetoclax-based chemotherapy combinations in aml
-
3:12
optimal use of venetoclax in aml
-
7:55
comparison of venetoclax-based versus non-venetoclax-based treatment regimens in aml
-
2:12
aml: options after venetoclax-based regimen failure
-
1:40
oral combination of hmas venetoclax in unfit or elderly patients with aml
-
2:43
venetoclax azacitidine in unfit patients with aml
-
3:59
treatment cessation using venetoclax-based therapy for older patients with aml
-
7:53
considerations for treating with venetoclax in aml
-
3:25
treatment approaches for elderly/unfit patients with aml ineligible for intensive chemotherapy
-
19:46
venetoclax-based strategies in aml
-
4:11
venetoclax based combination therapy in aml: a real-world retrospective analysis
-
1:07
challenges in treating aml
-
2:49
venetoclax and azacitidine for young patients with aml
-
2:33
upcoming clinical trials for venetoclax chemotherapy combinations for aml
-
2:08
venetoclax-based quadruplet therapy with trametinib for patients with ras-mutated aml and mds